Cargando…

An integrated approach to determine left atrial volume, mass and function in hypertrophic cardiomyopathy by two-dimensional echocardiography

METHODS: The study included 25 hypertrophic cardiomyopathy (HCM) patients (15 non-obstructive and 10 obstructive) and 25 controls for assessment of left atrial (LA) volume, mass and function by two-dimensional echocardiography. Measurement included mean LA diameter (LAD), LA mass = {(mean LAD + ante...

Descripción completa

Detalles Bibliográficos
Autores principales: Anwar, Ashraf M., Soliman, Osama I. I., Nemes, Attila, Geleijnse, Marcel L., ten Cate, Folkert J.
Formato: Texto
Lenguaje:English
Publicado: Springer Netherlands 2007
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2121119/
https://www.ncbi.nlm.nih.gov/pubmed/17541727
http://dx.doi.org/10.1007/s10554-007-9224-x
_version_ 1782141653826404352
author Anwar, Ashraf M.
Soliman, Osama I. I.
Nemes, Attila
Geleijnse, Marcel L.
ten Cate, Folkert J.
author_facet Anwar, Ashraf M.
Soliman, Osama I. I.
Nemes, Attila
Geleijnse, Marcel L.
ten Cate, Folkert J.
author_sort Anwar, Ashraf M.
collection PubMed
description METHODS: The study included 25 hypertrophic cardiomyopathy (HCM) patients (15 non-obstructive and 10 obstructive) and 25 controls for assessment of left atrial (LA) volume, mass and function by two-dimensional echocardiography. Measurement included mean LA diameter (LAD), LA mass = {(mean LAD + anterior LA wall + posterior LA wall)(3) − mean LAD(3)} × 0.8 + 0.6, LA volume = [(8/3 π L · A1 · A2), where L is LA length, A1 and A2 are LA area in 4-chambers and 2-chambers, respectively] including maximum (V(max)), minimum (V(min)), and pre-atrial contraction (V(pre-A)), total atrial stroke volume (TA-SV), TA emptying fraction (TA-EF), active atrial SV (AA-SV), AA-EF, passive atrial SV (PA-SV), PA-EF, atrial expansion index (AEI), and LA kinetic energy (LA-KE) = ½ × AA-SV × P × V(2). RESULTS: LAD, LA mass, V(max), V(min), and V(pre-A) were significantly higher in HCM than controls. TA-SV and TA-EF were comparable in both HCM subgroups and controls. AA-SV and LA-KE were significantly higher in both HCM subgroups than controls. LA-KE was significantly higher in obstructive HCM than non-obstructive (P < 0.001). PA-EF and AEI were significantly lower in obstructive HCM than controls (P < 0.05). CONCLUSION: HCM is associated with increased LA size and augmented LA pump function especially obstructive type. LA conduit and reservoir functions are impaired in obstructive HCM.
format Text
id pubmed-2121119
institution National Center for Biotechnology Information
language English
publishDate 2007
publisher Springer Netherlands
record_format MEDLINE/PubMed
spelling pubmed-21211192007-12-07 An integrated approach to determine left atrial volume, mass and function in hypertrophic cardiomyopathy by two-dimensional echocardiography Anwar, Ashraf M. Soliman, Osama I. I. Nemes, Attila Geleijnse, Marcel L. ten Cate, Folkert J. Int J Cardiovasc Imaging Original Paper METHODS: The study included 25 hypertrophic cardiomyopathy (HCM) patients (15 non-obstructive and 10 obstructive) and 25 controls for assessment of left atrial (LA) volume, mass and function by two-dimensional echocardiography. Measurement included mean LA diameter (LAD), LA mass = {(mean LAD + anterior LA wall + posterior LA wall)(3) − mean LAD(3)} × 0.8 + 0.6, LA volume = [(8/3 π L · A1 · A2), where L is LA length, A1 and A2 are LA area in 4-chambers and 2-chambers, respectively] including maximum (V(max)), minimum (V(min)), and pre-atrial contraction (V(pre-A)), total atrial stroke volume (TA-SV), TA emptying fraction (TA-EF), active atrial SV (AA-SV), AA-EF, passive atrial SV (PA-SV), PA-EF, atrial expansion index (AEI), and LA kinetic energy (LA-KE) = ½ × AA-SV × P × V(2). RESULTS: LAD, LA mass, V(max), V(min), and V(pre-A) were significantly higher in HCM than controls. TA-SV and TA-EF were comparable in both HCM subgroups and controls. AA-SV and LA-KE were significantly higher in both HCM subgroups than controls. LA-KE was significantly higher in obstructive HCM than non-obstructive (P < 0.001). PA-EF and AEI were significantly lower in obstructive HCM than controls (P < 0.05). CONCLUSION: HCM is associated with increased LA size and augmented LA pump function especially obstructive type. LA conduit and reservoir functions are impaired in obstructive HCM. Springer Netherlands 2007-05-31 2008-01 /pmc/articles/PMC2121119/ /pubmed/17541727 http://dx.doi.org/10.1007/s10554-007-9224-x Text en © Springer Science+Business Media, Inc. 2007
spellingShingle Original Paper
Anwar, Ashraf M.
Soliman, Osama I. I.
Nemes, Attila
Geleijnse, Marcel L.
ten Cate, Folkert J.
An integrated approach to determine left atrial volume, mass and function in hypertrophic cardiomyopathy by two-dimensional echocardiography
title An integrated approach to determine left atrial volume, mass and function in hypertrophic cardiomyopathy by two-dimensional echocardiography
title_full An integrated approach to determine left atrial volume, mass and function in hypertrophic cardiomyopathy by two-dimensional echocardiography
title_fullStr An integrated approach to determine left atrial volume, mass and function in hypertrophic cardiomyopathy by two-dimensional echocardiography
title_full_unstemmed An integrated approach to determine left atrial volume, mass and function in hypertrophic cardiomyopathy by two-dimensional echocardiography
title_short An integrated approach to determine left atrial volume, mass and function in hypertrophic cardiomyopathy by two-dimensional echocardiography
title_sort integrated approach to determine left atrial volume, mass and function in hypertrophic cardiomyopathy by two-dimensional echocardiography
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2121119/
https://www.ncbi.nlm.nih.gov/pubmed/17541727
http://dx.doi.org/10.1007/s10554-007-9224-x
work_keys_str_mv AT anwarashrafm anintegratedapproachtodetermineleftatrialvolumemassandfunctioninhypertrophiccardiomyopathybytwodimensionalechocardiography
AT solimanosamaii anintegratedapproachtodetermineleftatrialvolumemassandfunctioninhypertrophiccardiomyopathybytwodimensionalechocardiography
AT nemesattila anintegratedapproachtodetermineleftatrialvolumemassandfunctioninhypertrophiccardiomyopathybytwodimensionalechocardiography
AT geleijnsemarcell anintegratedapproachtodetermineleftatrialvolumemassandfunctioninhypertrophiccardiomyopathybytwodimensionalechocardiography
AT tencatefolkertj anintegratedapproachtodetermineleftatrialvolumemassandfunctioninhypertrophiccardiomyopathybytwodimensionalechocardiography
AT anwarashrafm integratedapproachtodetermineleftatrialvolumemassandfunctioninhypertrophiccardiomyopathybytwodimensionalechocardiography
AT solimanosamaii integratedapproachtodetermineleftatrialvolumemassandfunctioninhypertrophiccardiomyopathybytwodimensionalechocardiography
AT nemesattila integratedapproachtodetermineleftatrialvolumemassandfunctioninhypertrophiccardiomyopathybytwodimensionalechocardiography
AT geleijnsemarcell integratedapproachtodetermineleftatrialvolumemassandfunctioninhypertrophiccardiomyopathybytwodimensionalechocardiography
AT tencatefolkertj integratedapproachtodetermineleftatrialvolumemassandfunctioninhypertrophiccardiomyopathybytwodimensionalechocardiography